Naoki Kaneko
About
In The Last Decade
Naoki Kaneko
165 papers receiving 4.7k citations
Hit Papers
Peers
Comparison fields: 5 of 160
- Molecular Biology 1.4k
- Physiology 1.2k
- Psychiatry and Mental health 705
- Surgery 591
- Neurology 548
Countries citing papers authored by Naoki Kaneko
This map shows the geographic impact of Naoki Kaneko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoki Kaneko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoki Kaneko more than expected).
Fields of papers citing papers by Naoki Kaneko
This network shows the impact of papers produced by Naoki Kaneko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoki Kaneko. The network helps show where Naoki Kaneko may publish in the future.
Co-authorship network of co-authors of Naoki Kaneko
This figure shows the co-authorship network connecting the top 25 collaborators of Naoki Kaneko. A scholar is included among the top collaborators of Naoki Kaneko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoki Kaneko. Naoki Kaneko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 2 | |
| 3 | 3 | |
| 4 | 1 | |
| 5 | 0 | |
| 6 | 11 | |
| 7 | 2 | |
| 8 | 57 | |
| 9 | 17 | |
| 10 | 3 | |
| 11 | 4 | |
| 12 | Flow-Mediated Susceptibility of Cerebral Endothelia to Sars-CoV-2 Infection Using Endothelialized 3D Human Vascular Models | 1 |
| 13 | 15 | |
| 14 | High performance plasma amyloid-beta biomarkers for Alzheimer's disease | 160 |
| 15 | 75 | |
| 16 | 36 | |
| 17 | 19 | |
| 18 | 61 | |
| 19 | 57 | |
| 20 | 55 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.